Cargando…

Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report

The therapeutic effects of molecular targeted drugs are, in some cases, more pronounced than those of conventional chemotherapy, and their introduction as a standard treatment is increasing. The present report describes a case of ovarian insufficiency in a young woman caused by tyrosine kinase inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoki, Yoichi, Inoue, Yosuke, Sasahira, Naoki, Ono, Makiko, Inamura, Kentaro, Kataoka, Akemi, Takano, Toshimi, Kanao, Hiroyuki, Watanabe, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502945/ https://www.ncbi.nlm.nih.gov/pubmed/37720675 http://dx.doi.org/10.3892/ol.2023.14037

Ejemplares similares

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
por: Tateai, Yoshikazu, et al.
Publicado: (2023)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Minimally invasive diagnostic and therapeutic surgery for an intra-abdominal desmoid tumor: A case report
por: Omi, Makiko, et al.
Publicado: (2020)

Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma
por: Okubo, Hironao, et al.
Publicado: (2020)

Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis
por: Kanno, Motoko, et al.
Publicado: (2023)

Unexpected result of minimally invasive surgery for cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2018)

Transperineal endoscopic approach with GelPOINT V-path in laparoscopic pelvic exenteration for postirradiated recurrent cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2023)

Should indications for laterally extended endopelvic resection (LEER) exclude patients with sciatica?
por: Kanao, Hiroyuki, et al.
Publicado: (2020)

Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report
por: Takei, Shota, et al.
Publicado: (2023)

Early oral feeding is safe and useful after rectosigmoid resection with anastomosis during cytoreductive surgery for primary ovarian cancer
por: Kato, Kazuyoshi, et al.
Publicado: (2021)

Mucinous tumors arising from ovarian teratomas as another source of pseudomyxoma peritoneii: MR findings comparison with ovarian metastases from appendiceal mucinous tumors
por: Tanaka, Yumiko Oishi, et al.
Publicado: (2023)

Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy
por: Colombo, Carla, et al.
Publicado: (2018)

Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases
por: Omi, Makiko, et al.
Publicado: (2020)

Oncologic Outcomes of Laparoscopic Radical Hysterectomy Using the No-Look No-Touch Technique for Early Stage Cervical Cancer: A Propensity Score-Adjusted Analysis
por: Fusegi, Atsushi, et al.
Publicado: (2021)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2018)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Impact on prognosis of unexpected uterine sarcoma with scalpel morcellation or enucleation
por: Tanigawa, Terumi, et al.
Publicado: (2022)

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

Total Cholesterol Level for Assessing Pancreatic Insufficiency Due to Chronic Pancreatitis
por: Hirano, Kenji, et al.
Publicado: (2014)

Reconstruction of the diaphragm with autologous fascia lata during cytoreduction in patients with advanced ovarian cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2023)

Primary ovarian insufficiency
por: Brent, Shannon, et al.
Publicado: (2023)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
por: Mizokami, Ken, et al.
Publicado: (2022)

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
por: Tada, Toshifumi, et al.
Publicado: (2022)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma
por: Hiraoka, Atsushi, et al.
Publicado: (2020)

Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
por: Saito, Kei, et al.
Publicado: (2020)

Differences between laparoscopic super-radical hysterectomy and laterally extended endopelvic resection
por: Kanao, Hiroyuki, et al.
Publicado: (2021)

Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma
por: Imakura, Takeshi, et al.
Publicado: (2021)

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study
por: Hiraoka, Atsushi, et al.
Publicado: (2021)

Feasibility and Outcomes of “No-Look No-Touch” Laparoscopic Radical Trachelectomy for Early-Stage Cervical Cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2021)

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma
por: He, Min-Ke, et al.
Publicado: (2021)

Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma
por: Inukai, Yosuke, et al.
Publicado: (2023)

A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer
por: Takahashi, Shunji, et al.
Publicado: (2021)

Primary ovarian insufficiency: an update
por: Cox, Leticia, et al.
Publicado: (2014)

Association of Vitamin K Insufficiency With Cognitive Dysfunction in Community-Dwelling Older Adults
por: Azuma, Kotaro, et al.
Publicado: (2022)

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells
por: Izumi, Aya, et al.
Publicado: (2022)

Lenvatinib for Hepatocellular Carcinoma: A Literature Review
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
por: Lee, Matthew Man Pok, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mkjcm2usmspe0fp365tckeoarb